On this page
Elelyso
taliglucerase alfa
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Elelyso
Proper name
taliglucerase alfa
Licence type
351(a)
BLA number
022458
Applicant
Pfizer Inc.
Center
CDER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 200UNITS | For Injection | Intravenous | Single-Dose Vial | Rx | May 1, 2012 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |